Monday, Oct 21 2019 | Time 21:36 Hrs(IST)
image
  • Puri Gobardhan Math management to be vested in Jagatguru Shankaracharya
  • MMI plan should give utmost importance to pedestrian facilities, walkability: Baijal
  • India, Pak inch ahead on Kartarpur, but fee clause still an issue
  • Gujarat Assy bypolls: 51 36 pc voting recorded
  • Odisha to execute eight rural water piped projects at a cost of Rs 1324 83 crore
  • Indian Railways has started to carry e-commerce consignments on its EMU services
  • Police resort to mild lathi charge as NCP activists manhandle AIMIM MP Imtiyaz Jaleel in Aurangabad
  • Assembly polls witness low turnout, Haryana 65 pc, Maharashtra 60 5 pc till 1800 hrs
  • Around 51 pc turnout in Mah: 43 5 pc voting in Mumbai; 46 pc in Mah suburbs till 1700 hrs
  • Commonwealth FinMins urge progress on taxing digital commerce to tackle debt
  • SIT probing Kamlesh Tewari murder case conducts raids in Shahjahanpur
  • Commerce and Industry Minister on two-day visit to Sweden
  • Bijepur Assembly by poll in Odisha :72 per cent cast ballot
  • MoS Ashwini Chaube to attend BRICS Health Ministers Conference in Brazil
  • 61 92 pc turnout in MP by-poll; violence nil
Science Technology


WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

Kolkata, Aug 30 (UNI) The World Health Organization (WHO) has revised its guidance on

contraceptive use to reflect new evidence that women at high risk of HIV can use any form

of reversible contraception, including progestogen-only injectables, implants and intrauterine

devices (IUDs), without an increased risk of HIV infection.

However, as these contraceptive methods do not protect against HIV and other sexually

transmitted infections (STIs), the guideline emphasizes that correct and consistent use of

condoms should be used where there is a risk of STIs, including HIV, a WHO media

statement here on Friday said.

WHO also recommends considering offering pre-exposure prophylaxis (PrEP) in settings

where the incidence of HIV is above 3 per cent, as appropriate.

The updated WHO guideline follows a thorough review of the latest scientific evidence.

It emphasizes that women should have access to the full range of modern contraceptive

methods so they can make informed choices around contraceptive choice and their sexual

health.

“Evidence shows that a woman’s risk of HIV should not restrict her contraceptive choice,”

said Dr Peter Salama, Executive Director, Universal Health Coverage/Life Course at WHO.

“All women should have access to a wide range of options for contraception as well as to

HIV prevention and to treatment if needed.”

The updated recommendations to the WHO guideline, Medical eligibility criteria for

contraceptive use, stem from a review of the latest evidence conducted by the independent

Guideline Development Group convened to inform WHO.

This Group assessed all of the evidence on hormonal contraception and risk of HIV

acquisition published since the previous review published in 2016, along with a systematic

review of all published evidence on copper-bearing IUDs and HIV risk.

The new evidence is largely based on the results of the Evidence for Contraceptive

Options and HIV Outcomes (or ECHO trial) - a randomized clinical trial that showed no

statistically significant differences in HIV acquisition among women using intramuscular

depot medroxyprogesterone acetate (DMPA-IM), copper IUDs, or levonorgestrel (LNG)

implants.

This new high-quality evidence supersedes the low to low-moderate quality evidence

from observational studies that had been previously available to inform WHO’s guidance.

The ECHO study – which was conducted across communities expected to have high

levels of HIV prevalence in Eswatini, Kenya, South Africa and Zambia - also revealed

concerningly high levels of HIV acquisition and other sexually transmitted infections (STIs)

among women seeking contraceptive services, particularly younger women, irrespective

of which of the three contraceptive methods they used.

“There is a clear need to ensure women in Africa have access to high quality HIV and

STI prevention and testing services, along with a wide range of contraceptive options to

suit their values, preferences, views and concerns,” said Dr Felicitas Zawaira, Director of

Family and Reproductive Health in WHO’s African region.

“In high HIV prevalence settings, these may include condom promotion, pre-exposure

prophylaxis (PrEP), as well as linkages to antiretroviral therapy for those testing HIV-positive,

and partner testing.”

MORE UNI BM SJC

More News
SGRH completes 1000 Vascular Surgery cases in Artis Q Hybrid OR

SGRH completes 1000 Vascular Surgery cases in Artis Q Hybrid OR

04 Oct 2019 | 9:37 PM

New Delhi, Oct 4 (UNI) The Institute of vascular and endovascular sciences at Sir Ganga Ram Hospital (SGRH) has successfully completed 1000 cases of vascular surgery in Artis Q Hybrid OR.

see more..
Charting the 'Generic' terrain for future

Charting the 'Generic' terrain for future

26 Sep 2019 | 3:19 PM

By Rishira Jain
New Delhi, Sep 26 (UNI) For India to grow, healthcare, as the engine of the economy, needs to flourish and to make the affordable medication a reality, generic drugs is the only charted terrain in the country that can ensure affordable access to healthcare and the future sustainability of medicines development.

see more..
Fatty Liver a challenge for  Liver Transplant - liver transplant unit at CMRI

Fatty Liver a challenge for Liver Transplant - liver transplant unit at CMRI

22 Sep 2019 | 11:24 AM

Kolkata, Sep 22 (UNI) With obesity growing rampantly globally, a threat to liver diseases is increasing with every passing day.

see more..
'Smile Train India' partners with FOGSI  for early diagnosis of children with clefts

'Smile Train India' partners with FOGSI for early diagnosis of children with clefts

17 Sep 2019 | 7:23 PM

New Delhi, Sep 17 (UNI) 'Smile Train India' on Tuesday announced their collaboration with The Federation of Obstetric and Gynaecological Societies of India (FOGSI), to ensure early diagnosis and intervention for children with clefts.

see more..
WHO calls for urgent action to reduce patient harm in healthcare

WHO calls for urgent action to reduce patient harm in healthcare

14 Sep 2019 | 10:25 AM

Kolkata, Sep 14 (UNI) Millions of patients are harmed each year due to unsafe health care worldwide resulting in 2.6 million deaths annually in low-and middle-income countries alone.

see more..
image